Enveda, an AI drugmaker, banks $311M in venture funding
Enveda, which is using AI tools to mine plants and microbes for drug prospects, has three candidates in human testing for immune diseases and obesity.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.